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  We examined the expression of transferr；n receptor （TR） in transitlonal cell cancer （TCC）
immunohistologically， to clarify its implication in tumor malignancy． Forty eight out of 51 tumors
expressed TR while TR was not detected on the normal transitlonal eplthelium of renal pelvis，
ureter and urinary bladder． ln general， a higher grade and more lnvaslve TCC expressed TR
more frequently and more intensely． Furthermore， recurrent tumors treated with transurethral
resection significantly more ftequently expressed TR than the initial tumer． These results indicate
that the detection of TR on the tumor cells is useful for estlmating the degree of their malignancy．
                                （Acta Urol． Jpn． 37： 11－16， 1991）




















































































Table 1． Procedures of immunohistochemical
     stalnlng
1． air dry 30 min2． fixed in cold acetone 10 min
3． 20％ normat horse serum 30 rnin
4． first mouse monoclonal antibodies 60 min
5． biotinylated horse anti－mouse lg antibodies 30 min
 （Vector Laboratories）
6． streptavidin peroxidase 45 min （Amersham lnternational）
7． 0．05％ diaminobenzidin and O．Ol％ H20！ 3一一5min
Each step was followed by washing in PBS with three
changes of the buffer．
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Fig．1． （A）Transferrin receptor（TR）expres・
    sion on lymphoblast induced by two－way
    mixed lymphocyte culture with additlon
    of concanavalln・A（5μg／ml in culture
    medium）． Positive cells are scattered．
    （B）Normal transitiona且epithdial cells
    of urinary bladder stained with anti－
    transferrin receptor． No positivc cells
    wcre detected． Note the intense staining
    of lymphocytes in submucosal layer






Table 2． Expression of transferrin receptor
     （TR） in relation to tumor stage and
     grade
％ of transferrin receptor positive cell
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a：Figures in parentheses are the nurnber of cases with
transitional cell cancer of urinary bladder． ureter and renal
pelvis． respectively． Tumor grade is correlated with the
expression of TR significantly ｛ehi squre＝31 ．4． p〈O．Ol），
Fig． 2． （A）Grade 3 invasive （pT3） nodular
    tumor of urinary bladder． Hematoxylin
    and eosin－stained section． （B） Stained
    with anti－transferrin receptor． Nearly
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              や獅  努げ（A） Grade 2 non－invasive （pTl） papil－lary tumor of urinary bladder． Hema－
toxylin and eosin－stained section． （B）
Stained with anti－transfcrrin receptor．





Fig． 4． Grade 3 carcinoma in situ revealed high
   pos tivity of transferrin receptor． Bar＝









Table S． ComParison of transferrin receptor
     expressi on between initial and recur－
     rent tumor treated by transurethral
     resectlon
％ of transferrin receptor positive cetl











Recurrent tumor more frequently expressed TR than













































































































1） Trowbridge IS， Nawman RA， Domingo DL，
  et al．： Transferrin receptors： structure and
  function，． Biochem Pharmacol 33； 925－937．
                                   ’  1984
2） Hayashi 1 and S ato GH： Replacement of
  serum by hormones permits growth ot’ cells
  ・in，a defined medium． Nature 259： 132－134，
  1976
3） Barnes D and Sato G： Serum－free cell cul－
  ture： a unlfying approach． Cell 22・： 649－65S，
  1980
4） Galbraith GMP， Galbraith RM and Faulk
  WP： Transferrin binding by human lytnpho－
  blastoid cell lines and other transformed
  cells． Cell lmmunol 49： 215－222， 1980
5） Gatter KC， Brown G， Trowbridge IS， et aL：
  Transferrin receptors in hu．man tis．sues： their
  distribution and possible clinical relevance．
  J Clin Pathol 36： 539－545， 1983
6） ’Faulk WP， Hsi B and Stevens PJ： Transfer－
  rin and transferrin receptors in carcinoma
  of the breast． Lancet II： 390－392， 1980
7） Shindelman JE， Ortmeyer AE and Sussman
   HH： Demonstration of the transferrin re－
   ceptor in human breast cancer tissue： poten－
   tial marker for identifying dividing cells．
   Int J Cancer 27： 329－334， 1981
8） Mederios LJ， Picker LJ， 1｛orning SJ， et
   al．：’ Transferrin receptor expression by
   non－Hodgkin’s lymphomas： correlatlon with
   morpho1ogic grade and survival． Caricer 61 ：
   1844－1851， 1988
9） Ekblom P， Thesleff 1， Lehto V－P， et al．：
   Distribution of the transferrin receptor in
   norrnal human fibroblasts and fibrosarcoma
   cells． lnt J Cancer 31： 111－117， 1983
10） Seymour GJ， Walsh MD， Lavin MF， et
   al．： Transferrin receptor expression by
   human bladder transitional cell carcinomas．
   Urol Res 15； 34｝一344． 1987
                   －
11） PhMips JH， Le AM and Lanier LL ： Natu－
   ral killer cells activated ln a human mixed
   lymphocyte response culture identlfied by
   expression of Leu－ll and class II histocom－
   patibility antigens． J Exp Med 159： 993－
   1008， 1984
12） Bonnard C， Depermaster DS and Kraehen－
   buhl JP ： The streptavidin－biotin bridge
   technique： application in light and electron
   microscope immunocytochemistry． ln： lm－
   munolabelling for electron microscopy． Ed－
   ited by Polak JM and Varndell IM． pp． 9J”一・
   111， Elasevier Scientific Pub．， Amsterdam，
   1984
                          Monoclonal
   antibody to transferrin receptor blocks trans－
   ferrin binding and inhibits human tumor
   cell growth in vitro． Proc Natl Acad Sci
   USA 79： 1175－1179， 1982
16） Taetle R， Honeyg． ett JM and Trowbridge 1：
   Effects of anti－transferrin， receptor antibodies
   on growth of normal and malignant myeloid
   cells． lnt J Cancer 32： 343－349， 1983
17）Scott CF Jr， Goldmacher VS， Lambert
   JM， et aいAn immunotoxin composed of a
   morioc on l antitrang． ferrin receptor anti－
   body linked by a disulfide bond to・the
   ribosome－inactivatinsT protein gelonin： 1）o－
  tent in vitro and in vixro effects against
  human tumors． JNCI 79： 1163－1172， 1987
18） Plrker R， ITitzgerald DJ， Hamilton TC，
i3） Hernmingsen L， Rasmussen F， Skaarup P，
   et al．： Urinary protein profiles in patients
   with urothelial bladder tumors． Br J Urol
  53： 324－329， ．1981
114） T［／”rowbridge IS and D’omingo D’L： Anti－
  transferrin receptor inonoclonal antibody
   and toxin－antibody conjugates affect growth
   of human tumor cells、 Nature 294：1．7レ
   173， 1981
15） Trowbridge IE and Lopez F：
i6 泌尿系己要  37巻
   et al・： Anti transferrin receptor antibody
   linked to pseudomonas exotoxin as a model
   immunotoxin in human ovarian carcinoma
   cell lines． Cancer Res 45： 751－757， 1985
19） Kanellos J， Pietersz GA and McKenzie FC：
   Studies of methottexate－monoclonal anti－
   body conjugates fdr immunotherapy． JNCI
1号 1991年
   75： 319－329， 1985
20）Fitzgerald DJ，’ Bjorn MJ， Ferris RJ， et
   al．： Antitumor activity of an immunotoxin
   in a nude mouse model of’ human ovarian
   cancer． Cancer Res 47’： 1・407－1410， 1987
                （Received on March 5， 1990Accepted on Aprill 7， 1990）
